Ypsilon Therapeutics, a portfolio company of 82VS, Alloy’s venture studio, has been awarded $2.7 million in seed funding from ...

Abcellera, for example, designed Lily’s COVID antibody ... business of drug discovery, find promising targets, and then sell them to pharma to carry out the expensive process of development ...

AI tools are being combined into virtual screening platforms that can accelerate multiple steps in the drug discovery process ... with a PredAI that can model antibody-antigen interactions ...

Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

The company will use the seed capital to develop clinical programs, A.I. platforms and its drug candidate pipeline. Manas AI will host its systems on Microsoft (MSFT)’s Azure cloud computing ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...

Fundraiser Captain Sir Tom Moore's name has been dropped from the foundation set up in his honour. The Captain Tom Foundation is now known as the 1189808 Foundation, reflecting the organisation's ...

It didn’t even come from minority owner Tom Brady, who wasn’t present Monday ... suggesting Brady was “intricately involved” in the hiring process. “He could not be here (Monday ...

These venues for discussion and debate are essential for allowing the scientific process to unfold. The National Academies of Sciences, Engineering, and Medicine are the nation's pre-eminent source of ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.